The Economic Case for Vaccination: A Critical Analysis

The ongoing challenges posed by infectious diseases like influenza, measles, and COVID-19 have intensified discussions about the economic implications of vaccination. Public health officials advocate for vaccination as a crucial and cost-effective strategy to mitigate the impacts of these diseases, emphasizing not only health benefits but also significant economic advantages. As Canada confronts a resurgence of the H3N2 flu strain and a new variant of COVID-19, the importance of understanding the economic dimensions of vaccination becomes increasingly clear.

Understanding the Economic Impact of Vaccination

Vaccination programs extend beyond enhancing quality of life; they are fundamentally linked to economic performance. Historical context reveals that during the Vietnam War, the U.S. Congress considered cutting funding for measles immunizations to redirect resources. However, a pivotal study published in 1969 by researchers Axnick, Shavell, and Witte demonstrated the substantial economic benefits of maintaining a robust vaccination program.

This study estimated that while the direct costs of the measles vaccination program amounted to about $108 million, the avoided costs associated with the cancellation of the vaccination program could result in lifetime productivity losses of approximately $531 million. Such findings illustrate the critical nature of vaccination in not just protecting public health but also enhancing economic stability.

Categories of Economic Costs Associated with Disease

The economic costs of infectious diseases can be categorized into three main types: direct, indirect, and intangible. Direct costs include the price of vaccines and their distribution. In contrast, indirect costs encompass losses related to sick children missing school, which leads to educational delays, and productivity losses for caregivers. For instance, children who develop complications, such as encephalitis, may require lifelong care, resulting in rapid escalation of costs.

Intangible costs represent the broader economic impact of lost potential. The loss of life among children not only removes future contributors to the economy but also affects the long-term economic landscape. Children might have decades of productive work ahead, making their premature deaths a significant economic detriment.

Recent studies focus on the economic burden of seasonal flu, estimating that it costs the U.S. economy between $50 billion and $90 billion annually, with Canada facing losses around $5 billion. These figures highlight the pressing need for effective vaccination strategies as a means of not merely improving public health but also bolstering economic resilience.

Despite these insights, vaccination rates in Canada have recently declined compared to 2024. This trend can be attributed to both a general inertia in public health behaviors and misinformation campaigns that highlight adverse effects from vaccines, overshadowing the broader benefits of immunization.

For example, concerns about myocarditis, a rare side effect associated with COVID-19 vaccinations, have disproportionately affected young men. Yet, it is essential to weigh this against the significantly higher risk of myocarditis associated with COVID-19 itself. Thus, vaccination remains a vital public health strategy.

Behavioral economics offers further insights into vaccination decisions. The principle that “familiarity breeds contempt” suggests that individuals consistently vaccinated may undervalue additional doses over time. This phenomenon, coupled with the fading memories of past vaccination experiences, can lead to decreased immunization rates.

Moreover, the concept of externalities illustrates how vaccination serves both individual and community interests. The recent loss of Canada’s measles elimination status underscores the importance of maintaining high vaccination rates. With a basic reproduction number (R0) of between 12 and 18, measles spreads rapidly in unvaccinated populations, making herd immunity critical.

The effectiveness of the measles vaccine, which sits at about 95 percent, is jeopardized as vaccination rates decline. Maintaining rates above 90 percent is necessary to prevent outbreaks and protect community health.

Game theory further elucidates the complexities of vaccination. When vaccination rates reach levels sufficient for herd immunity, individuals may opt to become “free riders,” relying on the immunity of others without getting vaccinated themselves. If vaccination rates dip below 80 percent, the risk of disease resurgence increases significantly.

Ultimately, the economic implications of infectious diseases are profound. Vaccination is not merely a health intervention; it is a critical economic strategy that influences productivity, public health, and community well-being. As we continue to navigate the challenges posed by infectious diseases, recognizing the intertwined nature of health and economics is essential for informed public policy and community health initiatives.

Gregory Mason is an associate professor of economics at the University of Manitoba. This article was originally published in the Winnipeg Free Press.